The primary objective of this sub-study, 2018-10B, is to collect blood specimens to assess new biomarkers for the detection of Colorectal Cancer (CRC).
Subjects who consent to enroll in Exact Sciences Protocol 2018-10, will be asked to participate in this sub-study. Subjects enrolled in the Exact Sciences Protocol 2018-10, who provide written informed consent to participate in this sub-study, will have a blood sample collected at enrollment.
Study Type
OBSERVATIONAL
Enrollment
871
Subjects participating in the study will have blood drawn at enrollment.
Blood-based biomarkers associated with genetic and epigenetic alterations.
Biomarkers under evaluation include differential methylation of nucleic acids and altered expression of proteins in blood from subjects at average risk for development of colorectal cancer.
Time frame: Point in time blood collection (1 day) at enrollment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Mayo Clinic Arizona
Phoenix, Arizona, United States
Ventura County Gastroenterology
Camarillo, California, United States
Alliance Research Centers
Laguna Hills, California, United States
Focilmed
Oxnard, California, United States
Desert Oasis Healthcare Medical Group
Palm Springs, California, United States
Gastroenterology Associates of Fairfield County
Bridgeport, Connecticut, United States
Yale University Section of Digestive Diseases and Liver Diseases
New Haven, Connecticut, United States
Precision Clinical Research, LLC
Lauderdale Lakes, Florida, United States
Northshore University Health System Evanston Hospital
Evanston, Illinois, United States
DM Clinical Research- Southwest Gastroenterology
Oak Lawn, Illinois, United States
...and 27 more locations